Comparative Pharmacology
Head-to-head clinical analysis: LIPOSYN 20 versus NUTRILIPID 20.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LIPOSYN 20 versus NUTRILIPID 20.
LIPOSYN 20% vs NUTRILIPID 20%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Liposyn 20% is an intravenous fat emulsion providing essential fatty acids (linoleic and linolenic acids) and triglycerides. It serves as a caloric source and prevents essential fatty acid deficiency by supplying substrate for energy metabolism and cell membrane synthesis.
Nutrilipid 20% is an intravenous fat emulsion providing a source of calories and essential fatty acids. It is composed of soybean oil, egg yolk phospholipids, and glycerin. The triglycerides in the emulsion are hydrolyzed by lipoprotein lipase into free fatty acids and glycerol, which are then metabolized for energy production and incorporation into cell membranes.
Intravenous infusion: 1-2 g/kg/day (as soybean oil) initially, up to 2.5 g/kg/day, not to exceed 50% of total caloric intake; infusion rate not to exceed 0.1 g/kg/hour for first 30 minutes; if no adverse reactions, may increase to 0.2 g/kg/hour.
Intravenous infusion of 20% lipid emulsion: 1-2 g/kg/day (5-10 mL/kg/day) as part of parenteral nutrition; maximum infusion rate: 0.11 g/kg/h (0.55 mL/kg/h).
None Documented
None Documented
Triglyceride clearance half-life approximately 30-60 minutes; depends on lipase activity and clinical status.
The terminal elimination half-life of triglycerides in NUTRILIPID 20% is approximately 30 minutes in healthy adults with normal lipid metabolism. In critically ill or lipemic patients, clearance is delayed, and half-life can exceed 6 hours, necessitating monitoring of serum triglycerides.
Lipids are metabolized; <10% excreted renally as free fatty acids; biliary/fecal excretion minimal.
NUTRILIPID 20% is a lipid emulsion; triglycerides are cleared from plasma via hydrolysis by lipoprotein lipase into free fatty acids and glycerol, which are then metabolized. Renal excretion of intact triglycerides is negligible (<1%); elimination is primarily metabolic, with less than 5% excreted unchanged in urine or feces.
Category C
Category C
Intravenous Fat Emulsion
Intravenous Fat Emulsion